Research Archive - Express Pharma

Novartis’ Gilenya reduces brain shrinkage matters for people with MS

Schizophrenia has group of eight genetically distinct disorders

Merck Serono to discontinue clinical development programme of tecemotide

Glenmark’s TRPA1 antagonist shows positive data

Bone Therapeutics receives clearance

Spill resistant formulations: No crying over spilt syrups!

Sanofi’s dengue vaccine candidate completes efficacy study

Novartis’ Ultibro Breezhaler reduces COPD flare ups

Novartis’ KAE609 shows promise as next generation treatment for malaria

Merck Serono initiates phase II study of AntiPDL1 antibody in mMCC